Evaluation of immunity and protective efficacy of a dengue-3 premembrane and envelope DNA vaccine in Aotus nancymae monkeys

被引：36

作者：

Blair, PJ ^{[1
]}

Kochel, TJ ^{[1
]}

Raviprakash, K ^{[1
]}

Guevara, C ^{[1
]}

Salazar, M ^{[1
]}

Wu, SJ ^{[1
]}

Olson, JG ^{[1
]}

Porter, KR ^{[1
]}

机构：

[1] Naval Med Res Ctr, Silver Spring, MD 20910 USA

来源：

VACCINE | 2006年 / 24卷 / 09期

关键词：

dengue; DNA vaccine; Aotus monkeys;

D O I：

10.1016/j.vaccine.2005.09.032

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

A dengue (DEN) virus type 3 DNA vaccine expressing pre-membrane and envelope genes was tested for immunogenicity and protective efficacy in Aotus monkeys. Five of six vaccinated animals demonstrated moderate DEN-specific antibody responses as measured by ELISA and virus neutralization in vitro. By contrast, none of the six control animals developed detectable anti-DEN antibodies. When five vaccinated animals were challenged with live DEN-3 virus and viremia determined by PCR amplification of viral RNA in serum samples, one animal was completely protected and two were partially protected as indicated by a decrease in mean days of viremia. The results demonstrate the ability of the DEN-3 DNA vaccine to elicit a neutralizing antibody response and to partially protect against live virus challenge. These findings support the inclusion of this construct in a tetravalent DNA vaccine. Published by Elsevier Ltd.

引用

收藏

页码：1427 / 1432

页数：6

相关论文

共 29 条

[11] Inoculation of plasmids expressing the dengue-2 envelope gene elicit neutralizing antibodies in mice [J].

Kochel, T ;

Wu, SJ ;

Raviprakash, K ;

Hobart, P ;

Hoffman, S ;

Porter, K ;

Hayes, C .

VACCINE, 1997, 15 (05) :547-552

[12] A dengue virus serotype-1 DNA vaccine induces virus neutralizing antibodies and provides protection from viral challenge in Aotus monkeys [J].

Kochel, TJ ;

Raviprakash, K ;

Hayes, CG ;

Watts, DM ;

Russell, KL ;

Gozalo, AS ;

Phillips, IA ;

Ewing, DF ;

Murphy, GS ;

Porter, KR .

VACCINE, 2000, 18 (27) :3166-3173

[13] Effect of dengue-1 antibodies on American dengue-2 viral infection and dengue haemorrhagic fever [J].

Kochel, TJ ;

Watts, DM ;

Halstead, SB ;

Hayes, CG ;

Espinoza, A ;

Felices, V ;

Caceda, R ;

Bautista, CT ;

Montoya, Y ;

Douglas, S ;

Russe, KL .

LANCET, 2002, 360 (9329) :310-312

[14] RAPID DETECTION AND TYPING OF DENGUE VIRUSES FROM CLINICAL-SAMPLES BY USING REVERSE TRANSCRIPTASE-POLYMERASE CHAIN-REACTION [J].

LANCIOTTI, RS ;

CALISHER, CH ;

GUBLER, DJ ;

CHANG, GJ ;

VORNDAM, AV .

JOURNAL OF CLINICAL MICROBIOLOGY, 1992, 30 (03) :545-551

[15] DENGUE - THE RISK TO DEVELOPED AND DEVELOPING-COUNTRIES [J].

MONATH, TP .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (07) :2395-2400

[16] Recombination and flavivirus vaccines: a commentary [J].

Monath, TP ;

Kanesa-thasan, N ;

Guirakhoo, F ;

Pugachev, K ;

Almond, J ;

Lang, J ;

Quentin-Millet, MJ ;

Barrett, ADT ;

Brinton, MA ;

Cetron, MS ;

Barwick, RS ;

Chambers, TJ ;

Halstead, SB ;

Roehrig, JT ;

Kinney, RM ;

Rico-Hesse, R ;

Strauss, JH .

VACCINE, 2005, 23 (23) :2956-2958

[17]

Monath TP, 2002, CURR TOP MICROBIOL, V267, P105

[18] Clinical proof of principle for ChimeriVax™:: recombinant live, attenuated vaccines against flavivirus infections [J].

Monath, TP ;

McCarthy, K ;

Bedford, P ;

Johnson, CT ;

Nichols, R ;

Yoksan, S ;

Marchesani, R ;

Knauber, M ;

Wells, KH ;

Arroyo, J ;

Guirakhoo, F .

VACCINE, 2002, 20 (7-8) :1004-1018

[19] SIMPLIFIED PLAQUE REDUCTION NEUTRALIZATION ASSAY FOR DENGUE VIRUSES BY SEMIMICRO METHODS IN BHK-21-CELLS - COMPARISON OF THE BHK SUSPENSION TEST WITH STANDARD PLAQUE REDUCTION NEUTRALIZATION [J].

MORENS, DM ;

HALSTEAD, SB ;

REPIK, PM ;

PUTVATANA, R ;

RAYBOURNE, N .

JOURNAL OF CLINICAL MICROBIOLOGY, 1985, 22 (02) :250-254

[20] COMPLETE NUCLEOTIDE-SEQUENCE OF DENGUE TYPE-3 VIRUS GENOME RNA [J].

OSATOMI, K ;

SUMIYOSHI, H .

VIROLOGY, 1990, 176 (02) :643-647